TY - JOUR
T1 - Skeletal changes in epidermal nevus syndrome
T2 - Does focal bone disease harbor clues concerning pathogenesis?
AU - Heike, Carrie L.
AU - Cunningham, Michael L.
AU - Steiner, Robert D.
AU - Wenkert, Deborah
AU - Hornung, Robin L.
AU - Gruss, Joseph S.
AU - Gannon, Francis H.
AU - McAlister, William H.
AU - Mumm, Steven
AU - Whyte, Michael P.
PY - 2005
Y1 - 2005
N2 - Epidermal nevus syndrome (ENS) is a rare, sporadic, congenital disorder of unknown etiology featuring a complex and highly variable phenotype that can include focal or generalized skeletal disease. We describe a young man with ENS manifesting right-sided linear skin lesions, generalized weakness, diffuse osteopenia associated with hypophosphatemic rickets, and distinctive focal bone lesions ipsilateral to the skin findings. Review of the literature concerning ENS-associated skeletal disease suggested such focal bone defects are fibrous dysplasia, but our patient did not have the typical radiographic or histopathologic findings of fibrous dysplasia. Nevertheless, his circulating fibroblast growth factor 23 (FGF-23) level was elevated, likely functioning as a "phosphatonin," yet no activating mutations in GNAS previously reported in fibrous dysplasia or McCune-Albright syndrome were detected in his leukocytes or affected skin. We postulate that the focal skeletal disease, although different than fibrous dysplasia, may be a source of FGF-23 in ENS.
AB - Epidermal nevus syndrome (ENS) is a rare, sporadic, congenital disorder of unknown etiology featuring a complex and highly variable phenotype that can include focal or generalized skeletal disease. We describe a young man with ENS manifesting right-sided linear skin lesions, generalized weakness, diffuse osteopenia associated with hypophosphatemic rickets, and distinctive focal bone lesions ipsilateral to the skin findings. Review of the literature concerning ENS-associated skeletal disease suggested such focal bone defects are fibrous dysplasia, but our patient did not have the typical radiographic or histopathologic findings of fibrous dysplasia. Nevertheless, his circulating fibroblast growth factor 23 (FGF-23) level was elevated, likely functioning as a "phosphatonin," yet no activating mutations in GNAS previously reported in fibrous dysplasia or McCune-Albright syndrome were detected in his leukocytes or affected skin. We postulate that the focal skeletal disease, although different than fibrous dysplasia, may be a source of FGF-23 in ENS.
KW - Craniofacial asymmetry
KW - Dermatosis
KW - Fibroblast growth factor 23
KW - Fibrous dysplasia
KW - GNAS
KW - Hypophosphatemia
KW - McCcune-Albright syndrome
KW - Nevus unius lateris
KW - Osteopathy
KW - Pediatric
KW - Phosphatonin
KW - Rickets
UR - http://www.scopus.com/inward/record.url?scp=33645874795&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.30915
DO - 10.1002/ajmg.a.30915
M3 - Article
C2 - 16222671
AN - SCOPUS:33645874795
SN - 1552-4825
VL - 139 A
SP - 67
EP - 77
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 2
ER -